|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Enlarged follicles in women using oral contraceptives. |
| Broome M; Clayton J; Fotherby K |
| CONTRACEPTION. 1995 Jul;52(1):13-16. |
| In 1990, researchers in England enrolled 42 healthy women aged 21-46 attending the family planning clinic in |
| Reading in a study designed to determine whether a triphasic oral contraceptive (OC) affected ovarian cyst formation |
| any differently than did a progestogen-only pill (POP). They also wanted to ascertain the life span of any ovarian |
| cysts detected. 17 women used the triphasic OC containing various doses of ethinyl estradiol and levonorgestrel |
| (LNG). 15 women used either the POP Microval (30 mcg LNG) or Micronor (350 mcg norethisterone). The remaining |
| 10 women had used neither a steroidal contraceptive nor an IUD for at least six months. The researchers depended |
| on ultrasonography to detect enlarged ovarian follicles (>10 mm and <30 mm in diameter) and cysts (>30 mm |
| detected in 2nd half of cycle that persisted for more than 2 cycles). The women in the OC group underwent 53 |
| ultrasonic scans. Those in the POP group underwent 45 ultrasonic scans. Controls underwent 31 ultrasonic scans. |
| Only four women in the OC group had ovarian follicles, while 10 women did in the POP group and 7 in the control |
| group. Except for three follicles in two women, all the follicles were no more than 25 mm in diameter. The POP |
| group had a significantly higher proportion of ultrasonic scans detecting the presence of enlarged follicles than did |
| the OC group (14/45 vs. 4/53; p = 0.01). Since none of the enlarged follicles lasted for more than two cycles, there |
| were no functional ovarian cysts. These findings show that women using the triphasic OC had a lower incidence of |
| enlarged follicles than those using the POP and that the enlarged follicles were temporary. (PubHealth.info |
| Document ID: CONT2T 2591-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Enlarged follicles in women using oral contraceptives.", |
| is(are) Broome M; Clayton J; Fotherby K. The source of this article is "CONTRACEPTION. 1995 Jul;52(1):13-16.". |
| This article was published in 1995 in English language(s). (PubHealth.info® Document ID: CONT2T 2591-06. All |
| rights reserved with PubHealth.info) PIN: 7591 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
